Eligible participants will receive compensation for time and travel, acknowledging the value of your contribution to medical research.
Your participation helps improve treatment efficacy and accessibility, particularly for those with rheumatoid arthritis and Sjogren’s disease, ultimately improving the lives of millions.
We prioritize recruiting underrepresented populations, including Hispanic and African American patients, to ensure diverse representation in medical research and promote healthcare equity.
With extensive experience in vaccine trials and chronic disease research, our clinical team ensures a patient-focused, professional, and efficient research experience.
We value your comfort and convenience, offering flexible scheduling, full support from our research team, and clinical trial compensation. Your participation is voluntary, and you can withdraw at any time.
Sjogren’s disease is a chronic autoimmune disorder that primarily affects the body’s moisture-producing glands, leading to symptoms such as dry eyes, dry mouth, joint pain, and fatigue. This study is investigating potential new treatments to improve symptoms and overall quality of life.
Eligibility Criteria May Include:
Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic joint inflammation, pain, and stiffness. Our clinical trial is evaluating new treatment options that may help reduce symptoms and improve daily function for individuals living with RA.
Eligibility Criteria May Include:
